Abstract: The present invention provides a method and composition for promoting hair growth in a mammal which comprises a prostaglandin compound having two hetero atoms at the 15 position as an active ingredient thereof.

Abstract: The present invention provides a method and composition for promoting hair growth in a mammal which comprises a prostaglandin compound having two hetero atoms at the 15 position as an active ingredient thereof.

Abstract: Disclosed is a novel composition comprising a novel bi-cyclic compound, which is expected to be pharmaceutically active, and a glyceride. The stability of the bi-cyclic compound can be improved significantly by dissolving the same in a glyceride.

Abstract: Disclosed is a novel composition comprising a novel bi-cyclic compound, which is expected to be pharmaceutically active, and a glyceride. The stability of the bi-cyclic compound can be improved significantly by dissolving the same in a glyceride.

Abstract: Disclosed is a novel composition comprising a novel bi-cyclic compound, which is expected to be pharmaceutically active, and a glyceride. The stability of the bi-cyclic compound can be improved significantly by dissolving the same in a glyceride.

Abstract: Disclosed is a novel composition comprising a novel bi-cyclic compound, which is expected to be pharmaceutically active, and a glyceride. The stability of the bi-cyclic compound can be improved significantly by dissolving the same in a glyceride.

Abstract: Disclosed is a novel composition comprising a novel bi-cyclic compound, which is expected to be pharmaceutically active, and a glyceride. The stability of the bi-cyclic compound can be improved significantly by dissolving the same in a glyceride.

Abstract: The present invention provides a method and composition for promoting hair growth in a mammal which comprises a prostaglandin compound having two hetero atoms at the 15 position as an active ingredient thereof.

Abstract: Disclosed is a novel composition comprising a novel bi-cyclic compound, which is expected to be pharmaceutically active, and a glyceride. The stability of the bi-cyclic compound can be improved significantly by dissolving the same in a glyceride.

Abstract: The present invention provides a method for treating ocular hypertension and glaucoma, using a 15-keto-prostaglandin compound having a ring structure at the end of &ohgr; chain. The method of the present invention induces substantially no hair growth, which is a known side effect of conventional prostaglandin ophthalmic compounds such as latanoprost.

Abstract: Disclosed is a novel composition comprising a novel bi-cyclic compound, which is expected to be pharmaceutically active, and a glyceride. The stability of the bi-cyclic compound can be improved significantly by dissolving the same in a glyceride.

Abstract: An aromatic polycarbonate copolymer is useful for a substrate of an optical disk and is composed of 1 to 99 mole percent of the unit of 2,2-bis(4-hydroxy-3-tertiary-butyl-phenyl)propane, 99 to 1 mole percent of the unit of a comonomer selected from the group consisting of(1) 2,2-bis(4-hydroxyphenyl)propane,(2) 4,4'-dihydroxy-2,2,2-triphenylethane,(3) 2,2-bis(4-hydroxy-3-methylphenyl)-propane,(4) 1,1'-bis(4-hydroxyphenyl)-p-diisopropylbenzene,(5) 1,1'-bis(4-hydroxyphenyl)-m-diisopropyl-benzene,(6) 2,2-bis(4-hydroxyphenyl)butane,(7) 2,2-bis(4-hydroxyphenyl)-4-methylpentane,(8) 2,2-bis(4-hydroxyphenyl)octane,(9) 1,1-bis(4-hydroxyphenyl)cyclohexane and(10) 2,2-bis(3,5-dimethyl-4-hydroxyphenyl)propaneand a carbonate group located between the two units.